Healthcare management solutions provider Myriad Systems is interested in a minority stake sale and may run another formal process in 2027, said Jeremy Shiner, CEO and sole owner. Myriad came close to a minority stake sale three years ago but ultimately decided it was “not the right time” given expected future enhancements to its technology, especially around artificial intelligence (AI). The White Plains, New York-based company continues to field inbound approaches and is “very interested in talking to the right partner,” Shiner said. A proactive process is more likely in 2027, though, after receiving several expected patent approvals related to its technology, Shiner said.
Read the full article: Myriad Systems May Revisit Stake Sale in 2027 After Expected Patent Approvals – CEO //
Source: https://ionanalytics.com/insights/mergermarket/myriad-systems-may-revisit-stake-sale-in-2027-after-expected-patent-approvals-ceo/